Skip to main content
. 2024 Jun 5;39(11):968–978. doi: 10.1007/s00380-024-02422-5

Table 3.

Three months post-operative echocardiographic follow-up of patients alive at discharge (n = 53)

NR < 1.0 NR > 1.0
Survivors (n = 27) Non-survivors (n = 6) p value Survivors (n = 7) Non-survivors (n = 6) p value
sPAP, mmHga 33  ± 10* 51  ± 32 0.015 42  ± 14* 61  ± 30 0.16
TAPSE, mma 16  ± 3* 16  ± 3* 0.84 16  ± 3 15  ± 2 0.47
TAPSE/sPAP, mm/mmHga 0.55  ± 0.21* 0.47  ± 0.24 0.45 0.43  ± 0.17 0.26  ± 0.12 0.10
RVEDD, cma 3.4  ± 0.63* 3.4  ± 0.46* 0.83 3.7  ± 0.81* 4.1  ± 0.55 0.45
PAAT, msa 95  ± 20* 74  ± 28 0.064 89  ± 16* 92  ± 37 0.87

NR notch ratio, sPAP systolic pulmonary artery pressure, TAPSE tricuspid annular plane systolic excursion, RVEDD right ventricular end-diastolic diameter, PAAT pulmonary artery acceleration time

aMean ± SD

*p < 0.05 post-operative vs. pre-operative within group